Items where authors include "Horton, S"

Article

Brady, MC, Ali, M, VandenBerg, K et al. (65 more authors) (2022) Dosage, intensity, and frequency of language therapy for aphasia: a systematic review–based, individual participant data network meta-analysis. Stroke, 53 (3). pp. 956-967. ISSN 0039-2499

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Williams, LR, Ali, M, VandenBerg, K et al. (65 more authors) (2022) Utilising a systematic review-based approach to create a database of individual participant data for meta- and network meta-analyses: the RELEASE database of aphasia after stroke. Aphasiology, 36 (4). pp. 513-533. ISSN 0268-7038

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Ali, M, VandenBerg, K, Williams, LJ et al. (65 more authors) (2021) Predictors of poststroke aphasia recovery: a systematic review-informed individual participant data meta-analysis. Stroke, 52 (5). pp. 1778-1787. ISSN 0039-2499

Plein, S orcid.org/0000-0002-0997-4384, Erhayiem, B, Fent, G et al. (9 more authors) (2020) Cardiovascular effects of biological versus conventional synthetic disease-modifying antirheumatic drug therapy in treatment-naïve, early rheumatoid arthritis. Annals of the Rheumatic Diseases, 79 (11). pp. 1414-1422. ISSN 0003-4967

Emery, P orcid.org/0000-0002-7429-8482, Horton, S, Dumitru, RB et al. (5 more authors) (2020) Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial. Annals of the Rheumatic Diseases, 79 (4). pp. 464-471. ISSN 0003-4967

Brady, MC, Ali, M, VandenBerg, K et al. (65 more authors) (2020) RELEASE : a protocol for a systematic review based, individual participant data, meta- and network meta-analysis, of complex speech-language therapy interventions for stroke-related aphasia. Aphasiology, 34 (2). pp. 137-157. ISSN 0268-7038

Aydin, SZ, Castillo-Gallego, C, Nam, J et al. (4 more authors) (2017) The new ACR/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound. European Journal of Rheumatology, 4 (2). pp. 118-121. ISSN 2147-9720

Buch, MH orcid.org/0000-0002-8962-5642, Hensor, EMA, Rakieh, C et al. (8 more authors) (2017) Abatacept reduces disease activity and ultrasound power Doppler in ACPA-negative undifferentiated arthritis: a proof-of-concept clinical and imaging study. Rheumatology, 56 (1). pp. 58-67. ISSN 1462-0324

Dumitru, RB, Horton, S, Hodgson, R et al. (4 more authors) (2016) A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA). BMC Musculoskeletal Disorders, 17. 61. ISSN 1471-2474

Das, S, Vital, EM, Horton, S et al. (6 more authors) (2014) Abatacept or tocilizumab after rituximab in rheumatoid arthritis? An exploratory study suggests non-response to rituximab is associated with persistently high IL-6 and better clinical response to IL-6 blocking therapy. Annals of the Rheumatic Diseases, 73 (5). 909 - 912. ISSN 0003-4967